Copper-peptide research material catalogued for tissue-model studies.
- Dose
- 50 mg
- Batch
- 268005
GHK-Cu
Glycyl-L-histidyl-L-lysine copper(II) complex (GHK-Cu; prezatide copper; INCI copper tripeptide-1) · GHK
For research purposes only — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Copper-peptide research material catalogued for tissue-model studies.
Members get 10% off every order, on top of volume pricing — become a member with a free account.
Volume savings are applied automatically at checkout. Larger orders: support@alptide.ch
- Lab
- Janoshik Analytical
- Purity
- 99.365%
- Methods
- HPLC · LC-MS
- Tested
- Oct 2, 2026
For laboratory research use only. Not for human consumption.
Technical specifications
- Type
- Peptide
- Scientific name
- Glycyl-L-histidyl-L-lysine copper(II) complex (GHK-Cu; prezatide copper; INCI copper tripeptide-1)
- Amino acids
- 3
- Sequence
- GHK
- Molecular weight
- 402.92 g/mol
- Formula
- C14H23CuN6O4+
- CAS
- 89030-95-5
- Origin
- Tripeptide Gly-His-Lys isolated from human plasma in 1973 by Pickart and Thaler, complexed 1:1 with Cu(II); the uncomplexed GHK peptide is PubChem CID 73587, C14H24N6O4, 340.38 g/mol.
- Lyophilized (powder)
- -20°C, desiccated and protected from light · stable long-term
- Reconstituted
- 2-8°C · use within 30 days; do not re-freeze
- Room temperature
- Lyophilized powder tolerates short shipping excursions of a few days, but prolonged ambient storage promotes hydrolysis and loss of the copper complex; solutions should not be held at room temperature.
Peer-reviewed research
Published research and registered trials involving this compound. Provided for educational reference only — none of it is a claim about this product.
- Nature: New BiologyTripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liverPickart L, Thaler MM1973PMID: 4349963
- FEBS LettersStimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP1988DOI: 10.1016/0014-5793(88)80509-xPMID: 3169264
- Journal of Clinical InvestigationIn vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental woundsMaquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, Monboisse JC, Chastang F, Birembaut P, Gillery P, et al.1993DOI: 10.1172/JCI116842PMID: 8227353
- Journal of Investigative DermatologyExpression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+)Siméon A, Wegrowski Y, Bontemps Y, Maquart FX2000DOI: 10.1046/j.1523-1747.2000.00166.xPMID: 11121126
- Genome MedicineA gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHKCampbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, Suzuki M, Gosselink JV, Liu G, Alekseyev YO, Xiao J, Zhang X, Hayashi S, Cooper JD, Timens W, Postma DS, Knight DA, Lenburg ME, Hogg JC, Spira A2012DOI: 10.1186/gm367PMID: 22937864
- Journal of Orthopaedic ResearchTripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstructionFu SC, Cheuk YC, Chiu WYV, Yung SH, Rolf CG, Chan KM2015DOI: 10.1002/jor.22831PMID: 25731775
- International Journal of Molecular SciencesRegenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataPickart L, Margolina A2018DOI: 10.3390/ijms19071987PMID: 29986520
More in Repair
BPC-157
10 mg / vial
Synthetic research peptide catalogued for repair-and-recovery pathway studies.
TB-500
10 mg / vial
Synthetic research peptide catalogued for repair-and-recovery pathway studies.
AHK-Cu
50 mg / vial
Copper-complexed peptide research material catalogued for tissue-model studies.
BPC-157 + TB-500
20 mg / vial
Combined research-peptide blend catalogued for repair-and-recovery pathway studies.